Search Results - Ravi Radhakrishnan

Ravi Radhakrishnan

Ravi Radhakrishnan is an American engineer and an academic. He is the Herman P. Schwan Chair of Bioengineering as well as a professor in the Department of Chemical and Biomolecular Engineering at the University of Pennsylvania.

Radhakrishnan's work is centered around creating digital models for biomedical engineering applications, particularly in cancer treatment and nanomedicine. His work has also focused on computational algorithms across molecular and cellular scales, using machine learning, AI, statistical mechanics, and high-performance scientific computing on parallel architectures. His works have been published in academic journals, including ''Journal of Physics: Condensed Matter'' and ''Nature''. Provided by Wikipedia
  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Minimal mesoscale model for protein-mediated vesiculation in clathrin-dependent endocytosis. by Neeraj J Agrawal, Jonathan Nukpezah, Ravi Radhakrishnan

    Published in PLoS Computational Biology (2010-09-01)
    Get full text
    Article


  2. 2

    Editorial: Multiscale cancer modeling, in silico oncology and digital (virtual) twins in the cancer domain by Georgios S. Stamatakos, Maria Angeles Perez, Ravi Radhakrishnan

    Published in Frontiers in Physiology (2025-05-01)
    Get full text
    Article


  3. 3

    Towards verifiable cancer digital twins: tissue level modeling protocol for precision medicine by Sharvari Kemkar, Mengdi Tao, Alokendra Ghosh, Georgios Stamatakos, Norbert Graf, Kunal Poorey, Uma Balakrishnan, Uma Balakrishnan, Nathaniel Trask, Ravi Radhakrishnan, Ravi Radhakrishnan

    Published in Frontiers in Physiology (2024-10-01)
    Get full text
    Article


  4. 4

    Probing lipid membrane bending mechanics using gold nanorod tracking by Mehdi Molaei, Sreeja Kutti Kandy, Zachary T. Graber, Tobias Baumgart, Ravi Radhakrishnan, John C. Crocker

    Published in Physical Review Research (2022-03-01)
    Get full text
    Article


  5. 5

    Design of Inhibitors That Target the Menin–Mixed-Lineage Leukemia Interaction by Moses N. Arthur, Kristeen Bebla, Emmanuel Broni, Carolyn Ashley, Miriam Velazquez, Xianin Hua, Ravi Radhakrishnan, Samuel K. Kwofie, Whelton A. Miller

    Published in Computation (2023-12-01)
    Get full text
    Article


  6. 6

    Molecular hybridization strategy for tuning bioactive peptide function by Cibele Nicolaski Pedron, Marcelo Der Torossian Torres, Cyntia Silva Oliveira, Adriana Farias Silva, Gislaine Patricia Andrade, Yiming Wang, Maria Aparecida Silva Pinhal, Giselle Cerchiaro, Pedro Ismael da Silva Junior, Fernanda Dias da Silva, Ravi Radhakrishnan, Cesar de la Fuente-Nunez, Vani Xavier Oliveira Junior

    Published in Communications Biology (2023-10-01)
    Get full text
    Article


  7. 7

    Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering by Marshall S. Padilla, Kaitlin Mrksich, Yiming Wang, Rebecca M. Haley, Jacqueline J. Li, Emily L. Han, Rakan El-Mayta, Emily H. Kim, Sofia Dias, Ningqiang Gong, Sridatta V. Teerdhala, Xuexiang Han, Vivek Chowdhary, Lulu Xue, Zain Siddiqui, Hannah M. Yamagata, Dongyoon Kim, Il-Chul Yoon, James M. Wilson, Ravi Radhakrishnan, Michael J. Mitchell

    Published in Nature Communications (2025-01-01)
    Get full text
    Article


  8. 8

    Author Correction: Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering by Marshall S. Padilla, Kaitlin Mrksich, Yiming Wang, Rebecca M. Haley, Jacqueline J. Li, Emily L. Han, Rakan El-Mayta, Emily H. Kim, Sofia Dias, Ningqiang Gong, Sridatta V. Teerdhala, Xuexiang Han, Vivek Chowdhary, Lulu Xue, Zain Siddiqui, Hannah M. Yamagata, Dongyoon Kim, Il-Chul Yoon, James M. Wilson, Ravi Radhakrishnan, Michael J. Mitchell

    Published in Nature Communications (2025-10-01)
    Get full text
    Article


Search Tools: